Metabolic consequences of body size and body composition in hemodialysis patients  by Sarkar, S.R. et al.
Metabolic consequences of body size and body
composition in hemodialysis patients
SR Sarkar1, MK Kuhlmann1, P Kotanko1, F Zhu1, SB Heymsfield2, J Wang2, IS Meisels3, FA Gotch1,
GA Kaysen4 and NW Levin1
1Renal Research Institute and Beth Israel Medical Center, New York, USA; 2Body Composition Unit, St Luke’s Roosevelt Hospital, New
York, USA; 3Division of Nephrology, St Luke’s Roosevelt Hospital, New York, USA and 4Division of Nephrology, UC Davis, California, USA
Small body mass index is associated with increased mortality
in chronic hemodialysis patients. The reasons for this
observation are unclear but may be related to body
composition. This study aimed to investigate the body
composition in chronic hemodialysis patients. The difference
between body mass and the sum of muscle, bone,
subcutaneous, and visceral adipose tissue masses, measured
by whole body magnetic resonance imaging, was defined
as the high metabolic rate compartment representing the
visceral mass. Protein catabolic rate was calculated from urea
kinetics. Forty chronic hemodialysis patients (mean age 54.7
years; 87.5% African Americans; 45% females) were studied.
High metabolic rate compartment expressed in percent
of body weight was inversely related to body weight
(r¼0.475; P¼ 0.002) and body mass index (r¼0.530;
Po0.001). In a multiple linear regression model, protein
catabolic rate was significantly correlated only with high
metabolic rate compartment (r¼ 0.616; Po0.001). Assuming
that protein catabolic rate in addition to protein intake
reflects urea and uremic toxin generation, it follows that
high metabolic rate compartment is the major compartment
involved in their generation. Consequently, uremic toxin
production rate may be relatively higher in patients with
low body weight and low body mass index as compared to
their heavier counterparts. The poorer survival observed in
smaller dialysis patients may be related to these relative
differences.
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A decrease in mortality risk with higher body mass index
(BMI) was reported for the first time in a population of
mostly young, non-diabetic patients treated with mainte-
nance hemodialysis (HD) in France during the 1970s.1
Subsequently, several investigators have found a significant
inverse relationship between mortality risk and body size,
unaffected by adjustments for co-morbidities, in prevalent
and incident hemodialysis patients.2–4 The finding in the
HEMO study that women with lower BMI benefited from
higher doses of dialysis was explained as a possible reflection
of differences in body composition that accompany changes
in BMI.5 Dialysis dose is currently prescribed based on the
urea distribution volume (V); the basic assumption is that
body composition variability is not relevant and the only
difference between individuals having different values for V is
quantitative and not qualitative.
The human body can be roughly divided into two major
compartments, (1) total adipose tissue mass (TATM) and
(2) fat-free mass (FFM). Cellular compartments are in-
homogeneous with regards to function and metabolic rate.
Muscle, adipose tissue, and viscera each have different basal
rates of metabolic activity.
Differences in body composition affect whole body energy
expenditure, and the amount and types of metabolites
produced. Individuals having greater BMI usually have a
relatively greater amount of adipose tissue and a larger
skeletal muscle compartment, but only a slightly increased
internal organ compartment6 in comparison to individuals
having a lower BMI. Similarly, individuals having a greater
muscle mass (MM) do not have an accompanying propor-
tional increase in visceral mass.
Whole body metabolic rate is expressed by resting energy
expenditure (REE), which closely correlates with the size of
the FFM and even more precisely with body cell mass (BCM).
REE is the sum of the metabolic activities of internal organs,
muscle, bone, and adipose tissue. Each of these tissues has a
characteristic metabolic activity, with the highest metabolic
activity found in the internal organ compartment (225.9 kJ/
kg), compared to adipose tissue (18.8 kJ/kg), skeletal muscle
(54.5 kJ/kg), and bone compartments (9.6 kJ/kg).7 The
internal organ compartment has consequently been termed
the ‘high metabolic rate compartment’ (HMRC).6 Direct
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measurement of organ and tissue-specific REE is technically
difficult and has not been reported in dialysis patients.
However, regression models have been developed in non-HD
populations for estimation of whole body and HMRC-
specific REE from body composition models. These studies
utilize magnetic resonance imaging (MRI) to determine
tissue and organ volumes and take into account the tissue-
specific metabolic activities.6–8 Previous work in a non-HD
population has reported a good correlation without any
significant bias between predicted REE using MRI-derived
model and directly measured REE.6
Published studies in dialysis patients have not examined
the relationship of the range of body mass sizes to body
composition and accompanying predicted changes in meta-
bolism and energy generation. The present study aimed to
define body composition in a cross-sectional study of dialysis
patients utilizing MRI, total body potassium counting (TBK),
and deuterium (D2O) dilution techniques. These body
composition data were related to protein catabolic rate
(PCR) and were used to estimate REE.
RESULTS
Patient baseline characteristics
Forty chronic hemodialysis patients without any residual
renal function participated in the study (Table 1). The mean
age of the study population was 54.7710.7 years, 22 (55%)
were men, 35 (87.5%) were African Americans, three (7.5%)
were Hispanics/Caucasian, and two (5%) were Asians. BMI
was 27.674.8 kg/m2. Thirteen patients had diabetes mellitus
(32.5%), eight patients were positive for HIV infection
(20%). There was no difference in mean age and BMI
between males and females. Nutritional (albumin, creatinine,
PCR, normalized PCR (nPCR), and inflammatory para-
meters (CRP) were similar. The average pre-HD systolic and
diastolic blood pressures were 158728 and 89714 mmHg,
respectively. Average blood flow and dialysate flow rates were
362.7733.9 and 737.271122.8 ml/min, respectively; other
dialysis parameters are as shown in Table 1. The average
interdialytic weight gain was 3.8% of the dry weight.
There was a non-significant trend for lower subcutaneous
adipose tissue mass (SATM), in the HIV-positive patients
(15.075.2 vs 21.479.4 kg; P¼ 0.073), TATM, VAT, MM,
BCM, nPCR, serum creatinine, IL-6, and CRP were not
different between HIV-positive and -negative patients (data
not shown).
Body composition
One patient lacked TBK data and two patients had errors in
BIS measurements and were excluded from these specific
analysis (Tables 2 and 3; Figure 1a–d).
MM, bone mass (BM), HMRC (all by MRI), FFMBIS (by
bioimpedance), BCMTBK (by total
40K counting) and total
body water measured by deuterium oxide dilution method
(TBWD2O) were significantly higher in males. In females,
TATM and TATM expressed as percentage of body weight
(TATM%BW) were higher.
BMI correlated with TATM (r¼ 0.868; Po0.001; Figure
1a) and TATMBIS (r¼ 0.854; Po0.001). TATM was not
associated with age in either men or women (data not
shown). The correlations between BW and BMI and body
compartment masses (expressed in absolute terms and in
percent of BW) are shown in Table 3a and b and Figure 1a–c.
Absolute body compartment masses as determined by MRI
(visceral adipose tissue mass (VATM), SATM, TATM, MM,
BM, HMRC) were positively correlated with BW (all
Po0.001) and BMI (except for BM; P40.05). When
Table 1 | Patient characteristics, dialysis patterns, and nutritional indices by gender in a cohort of 40 HD patients
Male (n=22) Female (n=18)
Mean7s.d. Min Max Mean7s.d. Min Max
Age (years) 54.179.7 33 69 55.4711.9 33 73
Height (m) 1.7470.04 1.64 1.85 1.5970.06 1.49 1.71
Weight (kg) 83.4714.2 57.7 120 70.6717.6a 43.2 115.2
BMI (kg/m2) 27.574.3 19.4 38 27.775.5 19.4 41.1
Hemoglobin (g/dl) 12.0871.34 10.3 15.5 11.6171.36 9.5 14.1
Albumin (g/dl) 4.070.5 2.5 4.7 4.270.3 3.6 4.7
CRP (mg/dl) 0.771a 0.0 4.7 0.670.4b 0.0 1.4
PCR (g/day) 77.18722.9 29.9 125.5 66.6716.8 36.8 102.4
nPCR (g/kg/day) 1.0070.30 0.43 1.73 1.1570.24 0.59 1.15
Creatinine (mg/dl) 11.872.8 5.3 17.8 11.071.3 8.7 12.7
Dry weight (kg) 80.3713.7 56.7 114.5 66.4715.8* 41 106.3
Kinetic V (l) 44.2675.49 36.3 59.5 34.5676.80* 25.9 49.0
UFV (l) 3.571.1 0.8 5.5 3.271.2 1.5 6.0
UFR (ml/min) 1051.87319.6 230 1540 1008.37289.7 430 1600
Dialysis time (min) 212.9726.5 130 255 188.9738.0* 70 250
eKdrt/V 1.1770.17 0.9 1.5 1.4370.26* 0.9 2.0
URR 68.1874.85 58.0 76.0 73.8375.64* 60.0 82.0
BMI, body mass index; CRP, C-reactive protein; HD, hemodialysis; PCR, protein catabolic rate; nPCR, normalized PCR; UFV, ultrafiltration volume; UFR, ultrafiltration rate; URR,
urea reduction ratio.
*Po0.05 for between gender comparison.
an=19; bn=9.
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compartment masses were expressed as % of body weight
(Table 3b), BW and BMI correlated significantly (all
Po0.005) with HMRC%BW (Figure 1b and c), VATM%BW,
and BM%BW. TATM%BW correlated strongly with BMI and
weakly with BW. MM%BW was not correlated with BW or
BMI (values not shown).
FFM estimates by BIS (FFMBIS) and MRI (FFMMRI)
were highly correlated (r¼ 0.933; Po0.001). BCM estimated
from TBK (BCMTBK) correlated closely with FFMMRI
(r¼ 0.812; Po0.001). There was a strong correlation
between MM and TBWD2O (r¼ 0.889; Po0.001; Figure 1d)
indicating that higher TBWD2O was primarily due to
higher MM.
Resting energy expenditure
REE was estimated based on body composition data derived
from MRI (REEMRI). Estimated total REE was significantly
higher in males than in females (Table 2).
BMI tertiles
The entire population was divided into BMI tertiles to
further analyze the relationship between body composition,
HMRC mass, predicted REE, and PCR (Table 4a and b;
Figure 2a and b). PCR and TBWD2O were significantly higher
in the third (BMI range 28.9–41.1 kg/m2) compared to the
first tertile (BMI range 19.4–24.8 kg/m2). Albumin, creati-
nine, CRP, and nPCR were similar across the tertiles.
Except for BM, which was similar across the tertiles, there
was progressive increase of all tissue compartments, FFMBIS,
FFMMRI, BCMTBK, and REEMRI from lower to higher BMI
tertile. With declining BMI, HMRC%BW increased, whereas
VATM%BW and TATM%BW decreased (Figure 2a). Relative
contribution of HMRC-derived REE expressed as percent of
total REE (HMRC%REE) was higher in the lowest BMI tertile
(Figure 2b; Table 4b).
PCR and body composition (Table 5)
PCR as calculated by the kinetic model is directly derived
from urea generation rate. PCR was significantly higher in
the third BMI tertile compared to the first tertile (Tables 4a
Table 2 | Body composition and estimated REE by gender in the study cohort of 40 HD patients
Male (n=22) Female (n=18)
Mean7s.d. Min Max Mean7s.d. Min Max
MM (kg) 28.774.5 22.8 38.4 18.574.4* 12.6 29.9
TATM (kg) 20.578.9 5.7 45.5 26.1711.7 5.9 53.0
TATM%BW 23.676.8 8.9 37.9 35.679.0* 13.6 48.2
VATM (kg) 3.071.9 0.4 7.5 2.772.0 0.1 6.3
SATM (kg) 17.577.3 5.3 38.0 23.4710.1* 5.8 46.7
BM (kg) 14.271.8 7.9 17.1 10.271.5* 7.8 13.5
HMRC (kg) 20.072.5 14.4 25 15.773.2* 8.9 21.6
HMRC%BW 24.473.5 18.0 32.0 22.974.7 16.0 32.0
FFMMRI (kg) 65.977.6 51.4 82.2 48.478.9* 38.0 78.1
FFMBIS (kg) 59.878.4
a 46.8 76.1 42.6772.8* 32.3 58.2
BCMTBK (kg) 34.273.8
b 28.8 40.0 23.67 4.0* 18.6 31.3
TBWD2O (l) 45.674.9 36.5 54.2 34.475.7* 27.5 46.8
REEMRI (kJ/day) 66107774 4763 8106 515671034* 3378 7215
REEMRI/FFM (kJ/kg/day) 100.375.7 90.0 112.7 106.377.2* 89.0 119.0
BCMTBK, BCM by total body potassium counting; BM, bone mass; FFMBIS, FFM by bioimpedance spectroscopy; FFMMRI, FFM measured by MRI; HD, hemodialysis; HMRC, high
metabolic rate compartment; MM, muscle mass; REEMRI, REE estimated from MRI; SATM, subcutaneous adipose tissue mass; TATM, total adipose tissue mass; TBWD2O, total
body water by deuterium dilution method; VATM, visceral adipose tissue mass.
*Po0.05 for between gender comparison.
an=20; bn=21.
Table 3 | Correlation between body compartment masses
in absolute number and expressed as percentage of BW
with body weight (a) and BMI (b)
Body weight r P-value BMI r P-value
(a)
VATM 0.742 0.758
0.001 0.001
SATM 0.703 0.850
0.001 0.001
TATM 0.742 0.868
0.001 0.001
MM 0.814 0.539
0.001 0.001
BM 0.619 0.246
0.001 NS
HMRC 0.646 0.436
0.001 0.006
(b)
VATM%BW 0.510 0.567
0.001 0.001
SATM%BW 0.238 0.516
NS 0.001
TATM%BW 0.316 0.574
0.05 0.001
MM%BW 0.053 0.236
NS NS
BM%BW 0.462 0.718
0.003 0.001
HMRC%BW 0.477 0.530
0.002 0.001
BM, bone mass; BM%BW, bone mass in % of body weight; BMI, body mass index; BW,
body weight; HMRC, high metabolic rate compartment mass; HMRC%BW, high
metabolic rate compartment in % of body weight; MM, muscle mass; MM%BW, muscle
mass in % of body weight; SATM, subcutaneous adipose tissue mass; SATM%BW,
subcutaneous adipose tissue mass in % of body weight; TATM, total adipose tissue
mass; TATM%BW, total adipose tissue mass in % of body weight; VATM, visceral
adipose tissue mass; VATM%BW, visceral adipose tissue mass in % of body weight.
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and 5). PCR correlated with BW (r¼ 0.487; P¼ 0.002), BMI
(r¼ 427; P¼ 0.007), HMRC (r¼ 0.616; Po0.001), MM
(r¼ 0.467; P¼ 0.003), and weakly with VATM (r¼ 0.378;
P¼ 0.018). No correlation was observed between PCR and
SATM, TATM, and BM.
A backward multiple linear regression model with
PCR as the dependent variable and HMRC, MM, BW, VATM
as independent variables was developed. In this model,
absolute HMRC mass was the only significant predictor of
PCR (r¼ 0.616; Po0.001; Figure 3). PCR correlated with
none of the body compartments when related to BW
(HMRC%BW, MM%BW, SATM%BW, VATM%BW, BM%BW, and
TATM%BW).
DISCUSSION
The study aimed to assess body composition in chronic
hemodialysis patients and its relationship to measured PCR
and estimated REE. In order to explore this, we analyzed
body composition in 40 maintenance HD patients focusing
on the contribution of various organ/tissue compartments to
total body mass at different BMI levels. Several methods were
used to assess body composition, including whole body MRI,
total body potassium counting, bioimpedance spectroscopy,
and deuterium labeling of total body water.
The main finding of this study is that the relative
contribution of the high metabolic rate compartment to
body weight (HMRC%BW) is in both genders inversely related
to body weight and BMI. Lack of difference in CRP, albumin,
creatinine, and nPCR between gender and BMI tertiles argues
against any major effect of inflammation or malnutrition to
account for the observed differences.
PCR is directly derived from urea kinetics and is in general
used as a marker of nutritional status.9 PCR is positively
related to BW, and absolute masses of VATM, MM, and
HMRC. As absolute masses of VATM, MM, and HMRC
change according to BW, a multiple regression model was
used to account for those dependencies. With this approach,
HMRC mass was shown to be the only compartment
significantly related to PCR.
The correlation between HMRC and PCR, and not
between MM and PCR, may reflect the higher part
represented by visceral proteins than by muscle proteins in
whole body protein catabolism. In most stable patients, there
is equilibrium between protein intake and protein catabolism
and PCR may be interpreted as a marker of protein intake.9
This raises the possibility that the relation between PCR and
HMRC may be the result of a higher protein intake in
subjects with higher HMRC. On the other hand, as PCR
reflects urea generation, it can be in addition to protein
intake be interpreted as a surrogate of uremic toxin
generation from proteins, although this is an unresolved
topic and basis of much ongoing research.10
Our results indicate the HMRC as the prime uremiogenic
compartment. In general, uremic toxins are viewed as
metabolites retained in the body owing to a lack of renal
function. The source of uremic toxins has not been defined
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Figure 1 | Correlation of various body composition measures. (a) Correlation between total body adipose tissue mass (TATM, kg) and
body mass index (BMI, kg/m2). (b) Correlation between HMRC mass expressed as % body weight (HMRC%BW) and absolute body weight.
(c) Correlation between HMRC mass expressed as % body weight (HMRC%BW) and BMI. (d) Correlation between MM (kg) assessed by
MRI and total body water (TBW, L) assessed by D2O dilution technique.
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yet, but it may be assumed that most uremic toxins are
generated during metabolism in the liver, gut, and other
internal organs, which together constitute the HMRC. Uremic
toxin generation thus may be a function of visceral mass and
organ metabolic rate. Of note, skeletal muscle has not been
recognized as an important source of uremic toxins,11 and
owing to its water content may rather be considered as a
dilution compartment for uremic toxins.12 In our study, TBW
Table 4 | (a) Patient characteristics, dialysis patterns, and nutritional indices by BMI tertiles. (b) Body composition and
estimated REE by BMI tertile
BMI range (kg/m2) 1st tertile (n=13) 19.4–24.8 2nd tertile (n=13) 25.1–28.4 3rd tertile (n=14) 28.9–41.1
(a)
Age (years) 57.4713.2 56.179.1 51.078.9
Height (m) 1.770.1 1.670.1 1.770.1
Weight (kg) 64.1710.9 72.378.2* 95.3711.8**
BMI (kg/m2) 23.071.8 26.671.2 32.773.7
Albumin (g/dl) 4.170.3 4.070.7 4.070.4
CRP (mg/dl) 0.971.4a 0.570.4b 0.670.4c
PCR (g/day) 57.7716.6 71.6724.0 82.6717.9**
nPCR (g/kg/day) 0.9970.20 1.270.3 1.170.2
Creatinine (mg/dl) 11.872.0 10.272.4 12.172.1
Dry Weight (kg) 63.2712.8 6878.3* 89.8711.7**
UFV (l) 2.671.0 3.471.2 3.971.0**
UFR (ml/h) 8707358.5 10817231.4 1137.17259.7**
Dialysis time (min) 192721.8 187.7742.7* 224.8721.9**
eKdrt/V 1.2770.23 1.3770.29 1.2270.23
URR 70.176.7 73.275.5 6974.9
(b)
MM (kg) 20.475.5 22.375.6 29.375.8**
TATM (kg) 15.877.4 20.275.3 32.4710.0**
VATM (kg) 1.771.3 2.371.5 4.571.6**
SATM (kg) 14.276.4 17.975.0 27.879.0**
BM (kg) 11.372.3 12.572.0 13.373.0
HMRC (kg) 15.873.3 18.173.2 20.372.7**
HMRC%BW 25.3 7 4.6 24.6 7 3.4 21.5 7 3.4**
FFMMRI (kg) 50.6710.0 55.179.6 67.879.5**
FFMBIS (kg) 42.9710.0
c 50.278.2 59.9711.1**
BCMTBK (kg) 26.175.9 28.37 6.4 33.775.4
d,**
TBWD2O 37.077.3 39.077.1 45.476.3**
REEMRI (kJ/day) 5033.57955 5845.97859 6914.17773**
HMRC%REE (%) 70.374.6 69.973.2 66.273.9**
BCMTBK, BCM by total body potassium counting; BM, bone mass; BMI, body mass index; CRP, C-reactive protein; FFMBIS, FFM by bioimpedance spectroscopy; FFMMRI, FFM
measured by MRI; HMRC, high metabolic rate compartment; HMRC%BW, HMRC mass expressed as % body weight; HMRC%REE, REE from HMRC expressed as % of total REE;
MM, muscle mass; PCR, protein catabolic rate; nPCR, normalized PCR; REEMRI, REE estimated from MRI; SATM, subcutaneous adipose tissue mass; TATM, total adipose tissue
mass; TBWD2O, total body water by deuterium dilution method; UFV, ultrafiltration volume; UFR, ultrafiltration rate; URR, urea reduction ratio; VATM, visceral adipose tissue
mass.
*Po0.05 for 1st vs 2nd tertile.
**Po0.05 for 1st vs 3rd tertile.
an=10; bn=7; cn=11; dn=13.
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Figure 2 | Distribution of body compartment weights and resting energy expenditure across BMI tertiles. (a) Relative contribution of various
body compartments to total body mass across BMI tertiles; (b) fractional contribution of different body compartments to whole body REE.
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and MM correlated strongly which is in accordance with MM
being the main location of intracellular water.12
How do our findings contribute to the phenomenon of
‘reverse epidemiology’, which describes the fact that, in
contrast to the general population, higher BMI in dialysis
patients is associated with better survival?13,14 Even morbid
obesity confers a survival benefit in MHD patients.15
Although BMI is often used as an indicator of nutritional
status, BMI is not a good indicator of body composition, as it
does not differentiate between muscle and fat mass as main
contributors to BMI. BMI also does not reflect the
metabolically most active compartments. According to our
data, the mass of the HMRC relative to body weight becomes
lower as BMI increases, which could contribute to lower
uremic toxin generation rate and thus a lower uremic burden
per weight unit in heavier patients. In addition, as MM and
total body water volume increases with higher BMI, the
volume of distribution of uremic toxins increases and the
concentration of uremic toxins may be lower in subjects with
high BMI. We speculate that both vectors (relatively
lower generation and concentration of uremic toxins)
contribute to a survival advantage in MHD patients with
higher BMI.
The higher HMRC%BW in small patients translates into a
higher REEMRI per kg of FFM (Table 4a and b). This finding
has to be interpreted with caution, as we have not measured
REE directly but instead REE was estimated with equations
validated in healthy subjects only. There are various reports
in the literature on REE in HD patients measured by indirect
calorimetry. Some recent studies reported significantly
increased REE in HD patients when measured on non-HD
days16,17 and that the HD procedure itself increases REE
further by 5–10%16 with improvement in energy balance
using intradialytic parenteral nutrition.18 The reason for the
increased REE in HD patients is largely unexplained;
however, underlying state of inflammation in chronic kidney
disease,19 hyperparathyroidism,20 and other co-morbidities
(especially diabetes mellitus21) would result in increased REE.
The fact that the body composition measurements were
carried out before dialysis might affect the measurements of
BIA; however, it is unlikely to have any major effect on MRI
and TBK measurements.
Based on the present study, we are proposing the following
hypothesis: in HD patients who are naturally small, with a
small MM and TBW, uremic toxin generation from the
visceral mass will be relatively higher in relation to MM and
TBW, resulting in dilution of uremic toxins in a reduced
distribution volume. As dialysis dose (Kt/V) is generally
prescribed in accordance to total body water (V), this would
potentially lead to insufficient removal of uremic toxins in
patients with low BMI and low V. We understand that this
interpretation of our findings is hypothetical and that it needs
to be confirmed in larger group of dialysis patients, with
dialysis doses related to both total V and the mass of HMRC.
Table 5 | Results of the backward multiple regression analysis with PCR as the dependent variable and VATM, MM, HMRC, and
BW as the explanatory variable. Model (4) R2=0.380 (Po0.001)
Unstandardized coefficients 95% CI for B
Model Variable B Std. Error t Sig. Lower bound Upper bound
(1) Constant 7.95 17.49 0.45 0.65 27.60 43.51
VATM 3.86 2.56 1.51 0.14 1.33 9.06
MM 0.15 0.86 0.17 0.86 1.60 1.91
HMRC 3.79 1.18 3.22 0.00 1.40 6.18
BW 0.26 0.46 0.58 0.57 1.19 0.66
(2) Constant 6.74 15.83 0.43 0.67 25.40 38.88
VATM 3.69 2.33 1.58 0.12 1.04 8.43
HMRC 3.85 1.11 3.48 0.00 1.61 6.10
BW 0.21 0.33 0.63 0.53 0.88 0.46
(3) Constant 2.43 14.18 0.17 0.86 26.33 31.19
VATM 2.55 1.48 1.73 0.09 0.44 5.55
HMRC 3.37 0.80 4.22 0.00 1.75 4.99
(4) Constant 2.95 14.55 0.20 0.84 26.54 32.44
HMRC 3.75 0.79 4.76 0.00 2.15 5.34
VATM, visceral adipose tissue mass; MM, muscle mass; HMRC, high metabolic rate compartment mass; BW, body weight (all expressed in kg).
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Figure 3 | Relationship of measured PCR to HMRC mass.
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In conclusion, this is the first study to define body
composition in HD patients with direct measurement of
muscle, adipose tissue, bone, and visceral mass (high
metabolic rate compartment; HMRC) in relation to mea-
sured PCR and estimated REE. Our data show that in
hemodialysis patients, the relative contribution of the HMRC
to total body mass and of HMRC-derived REE to total REE
are higher in patients with low BMI compared to those with
high BMI and that PCR is significantly related to the size of
the high metabolic rate compartment.
MATERIALS AND METHODS
Protocol
Forty ambulatory patients maintained on hemodialysis for more than
3 months were enrolled in the study. Patients were studied in the
Body Composition Unit of St Luke-Roosevelt Hospital after an
overnight fast. All body composition studies were done 1–2 h before
dialysis. Patients agedo18 years, with metallic prostheses, claustro-
phobia, severe heart disease, or amputated limbs proximal to ankle or
wrist were excluded. The Institutional Review Boards of Beth Israel
Medical Center, New York, and St Luke’s Roosevelt Hospital, New
York, approved the study protocol and written informed consent was
obtained from each patient before entering the study.
All patients were hemodynamically stable and were treated as
outpatients three times a week with polysulphone dialyzers (F80s or
OptiFlux 200s, Fresenius Medical Care, Lexington, MA, USA). Pre-
dialysis blood samples were collected for determination of hemo-
globin, albumin, C-reactive protein (CRP) and creatinine levels.
Urea kinetic modeling data of the dialysis treatment were used
for the estimation of PCR.
PCR ¼ 9:35  G þ 0:29  V ð1Þ
where G is the urea generation and V is the urea distribution
volume. G is calculated with iteration of the variable volume double
pool model.22
Body composition
Details of the methodology have been published recently.23
Anthropometric measurements. Patients wore gowns; weight
(in kg) and height (in meters) were measured with the patients
barefoot using a beam-balance scale and wall-mounted stadiometer,
respectively.
Total-body 40K counting for determination of BCM. A natural
radioisotope of potassium, 40K, was used for estimation of total
body potassium, using a whole body counter as reported
previously.24 Once the subject’s 40K amount is known, total body
potassium (TBK, mmol) was estimated as:
TBK ¼40 K=0:0118 ð2Þ
BCM was estimated as:25,26
BCMTBK ¼ 0:0092  TBK ð3Þ
Deuterium (D2O) dilution method for determination of total body
water (TBWD2O).
Upon arrival at the testing laboratory, the subject ingested 10 g of
D2O (ICON, Summit, NJ, USA) and the dose rinsed three times
with 10 ml of regular water. Three hours after the dose, 7 ml blood
was taken in a heparinized tube for analysis by infrared spectro-
photometry (Avatar 360, Nicolet in Madison, WI, USA). The D2O
dilution space, measured with a CV of 1.2%, was converted into
TBW mass (in kg).25,27
MRI. MM, VATM, SATM, and BM were estimated by whole
body MRI.
FFMMRI was calculated as follows.
6
FFMMRI ¼Adipose tissue free mass þ 0:15  ðVATM þ SATMÞ ð4Þ
MRI of the whole body was carried out as reported by Gallagher
et al.7 Scans were prepared using a 1.5 Tesla scanner (General
Electric, 6X Horizon, Milwaukee, WI, USA). Subjects were placed in
a prone position with their arms extended overhead and B40 axial
images of 10-mm thickness were recorded from neck to foot at a
distance of 40-mm between each other. MRI provided estimates of
fat, muscle, and bone volumes, and a correction was made for
hydration of adipose tissue. All MRI scans were segmented into the
four components by trained analysts using the image analysis
software (Tomovision, Montreal, QC, Canada). In a multiple-step
procedure, a threshold was selected for adipose tissue and lean tissue
and lines were drawn around the selected regions by use of a
Watershead algorithm. Thereafter, tissues of interest were color-
labeled and the respective tissue areas (cm2) for each MRI image were
calculated by summing the specific tissue pixels and then multiplying
by the individual pixel surface area. The volume per slice (cm3) was
derived by multiplying tissue area with slice thickness and the
volume of each tissue for the space between two slices was calculated
and converted to mass units (kg) based on specific tissue densities.6
The difference between total body mass and fat, skeletal muscle,
and BMs was defined as HMRC in this paper. The HMRC includes
all the high metabolic rate organs6 such as heart, brain, liver,
kidneys, spleen, and gastro-intestinal tract.
Bioimpedance spectroscopy. Multifrequency bioimpedance
spectroscopy (BIS) was performed with a frequency range from
5 kHz to 1 MHz using the Xitron 4200 device (Xitron Technologies,
San Diego, CA, USA). Measurements were taken after the MRI and
before patients began dialysis.
FFM and percent body fat was estimated from BIS as follows28
Men:
FFMBISðkgÞ ¼ 10:68 þ 0:65S2=Resistance þ 0:26weight
þ 0:02resistance ð5Þ
Women:
FFMBISðkgÞ ¼ 9:53 þ 0:69S2=Resistance þ 0:17weight
þ 0:02resistance ð6Þ
S2=Resistance ¼ Stature ðheightÞÞ
2
resistance ðcm2=OÞ
%Body Fat ð%BFBISÞ ¼ 100½ðweight  FFMBISÞ=weight	 ð7Þ
Estimation of resting energy expenditure. REE was estimated
using the measured tissue compartments from MRI6
REEMRI ¼ 18:8FM þ 54:4MM þ 9:6BM
þ 225:9HMRC ð8Þ
Statistical methods
Data are expressed as means7s.d. Correlation coefficients were
estimated by the use of Pearson’s product moment coefficients.
Student’s t test was used to compare means between two measures,
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whereas analysis of variance with Bonferroni correction was used for
multiple comparisons. Multiple linear regression with backward
elimination (Po0.05 for retention) was used to model the
relationship between PCR as the dependent variable and MM,
HMRC, BM, VATM, and SATM as independent variables. P-values
o0.05 were considered significant and Bonferroni correction was
applied for multiple comparisons. Statistical analysis was performed
with SPSS version 11.5 (SPSS Inc., Chicago, IL, USA).
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ABBREVIATIONS
MM, muscle mass (kg); TATM, total adipose tissue mass (kg); VATM,
visceral adipose tissue mass (kg); SATM, subcutaneous adipose
tissue mass (kg); BM, bone mass (kg); HMRC, high metabolic rate
compartment mass (kg); HMRC%BW, high metabolic rate compartment
as % body weight; TATM%BW, total adipose tissue mass expressed as
% body weight; VATM%BW, visceral adipose tissue mass expressed as
% body weight; SAMT%BW, subcutaneous adipose tissue mass
expressed as % body weight; BM%BW, bone mass expressed as % body
weight; MM%BW, muscle mass expressed as % body weight; TBK, total
body potassium counting (mmol); BCMTBK, body cell mass measured
by TBK counting (kg); TBWD2O, total body water measured by
deuterium oxide dilution method (l); FFMBIS, fat free mass measured
by bioimpedance spectroscopy (kg); FFMMRI, fat free mass measured
by magnetic resonance imaging (kg); REE, resting energy expenditure;
REEMRI, resting energy expenditure predicted by MRI (kJ/day).
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